Maite Bourlon: Aging-related biomarkers in testicular cancer survivors after different oncologic treatments
Maite Bourlon shared a post on X about a recent paper by A. Carballo-Muñoz et al. published in Cancer Medicine.
“Aging-related biomarkers in testicular cancer survivors after different oncologic treatments”
Authors: A. Carballo-Muñoz, G. Lima, L. Llorente, Y. A. Remolina-Bonilla, S. Jaime-Casas, A. Otamendi-Lopez, R. A. Ortiz-Guerra, Hugo E. Velazquez, Y. Atisha-Fregoso, M. T. Bourlon.
“Aging-related biomarkers in testicular cancer survivors after different oncologic treatment.
PO-orchiectomy, chemo and BMT vs healthy controls
Chemo and BMT: immunosenescent phenotype and high CDKN2A/p16INK4a.”
Source: Maite Bourlon/X
Maria T Bourlon is an Associate Professor and Head of the Urologic Oncology Clinic at Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico. She is the Director of the Genitourinary Cancers Program at Universidad Nacional Autónoma de México.
Dr. Bourlon is the chair-elect of the American Society of Clinical Oncology IDEA Steering Group and in 2023 received the prestigious ASCO CCF International Women Who Conquer Cancer (WWCC) Mentorship Award. She is on the Editorial Board of OncoDaily.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023